SJS Investment Consulting’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1K Buy
223
+181
+431% +$15.3K ﹤0.01% 797
2026
Q1
$3.51K Sell
42
-51
-55% -$4.18K ﹤0.01% 1138
2025
Q4
$8.52K Buy
93
+85
+1,063% +$8.14K ﹤0.01% 820
2025
Q3
$759 Hold
8
﹤0.01% 1103
2025
Q2
$839 Sell
8
-3
-27% -$284 ﹤0.01% 928
2025
Q1
$973 Hold
11
﹤0.01% 1008
2024
Q4
$1.06K Sell
11
-2
-15% -$186 ﹤0.01% 982
2024
Q3
$1.06K Hold
13
﹤0.01% 1049
2024
Q2
$1.12K Hold
13
﹤0.01% 984
2024
Q1
$1.06K Hold
13
﹤0.01% 1013
2023
Q4
$862 Hold
13
﹤0.01% 1010
2023
Q3
$950 Buy
13
+5
+63% +$338 ﹤0.01% 965
2023
Q2
$506 Hold
8
﹤0.01% 1164
2023
Q1
$470 Sell
8
-6
-43% -$364 ﹤0.01% 1170
2022
Q4
$863 Buy
14
+1
+8% +$67 ﹤0.01% 1010
2022
Q3
$1K Buy
+13
New +$823 ﹤0.01% 755
2022
Q1
$0 Buy
+2
New +$108 ﹤0.01% 985

Other funds holding HQY

SJS Investment Consulting's HQY Position: Q2 2026 in Review

SJS Investment Consulting increased its HealthEquity (HQY) stake by 431% in Q2 2026, buying an estimated $15.3K and bringing the position to 223 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

SJS Investment Consulting first reported a position in HQY in Q1 2022 and has held it in 17 quarters since. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • SJS Investment Consulting held 223 shares of HealthEquity worth $20.1K as of Q2 2026.
  • SJS Investment Consulting bought 181 HealthEquity shares in Q2 2026, an estimated $15.3K.
  • HealthEquity made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #797 holding.
  • SJS Investment Consulting first reported a position in HealthEquity in Q1 2022 and has held it in 17 quarters since.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.